Futura Medical PLC (AIM:FUM, OTC:FAMDF) provided keen investors with further details about the US launch plans for its fast-acting gel for erectile dysfunction from blue-chip partner Haleon PLC.
The AIM-listed healthcare company said since yesterday, 1 September, Eroxon is now available for pre-order online for delivery next month.
88 Energy Ltd (AIM:88E, ASX:88E, OTC:EEENF) used today’s half-year financial report statement to give investors a rundown of its projects in Alaska, Texas, and Namibia.
Project Phoenix, in Alaska, remains a primary focus.
Roquefort Therapeutics PLC (LSE:ROQ, OTCQB:ROQAF) has passed a significant milestone with the European Patent Office, which granted a patent for its Mesodermal Killer (MK) cell therapy.
This intellectual property protection covers 39 countries, including the UK and the EU, and solidifies the company’s position in the rapidly growing field of cell-based immunotherapy.